James F Tessmer Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for James F Tessmer.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of James F Tessmer. James F Tessmer is VP, Finance & Accounting in LEXICON PHARMACEUTICALS, INC. ($LEXG).
Latest Insider Trading Transactions of James F Tessmer
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Feb 09 2015 | LEXG | LEXICON PHARMACEUT ... | Tessmer James F | VP, Finance & Accou ... | Option Exercise | A | 0.89 | 174,300 | 155,127 | 174,300 | |
Feb 09 2015 | LEXG | LEXICON PHARMACEUT ... | Tessmer James F | VP, Finance & Accou ... | Option Exercise | A | 0.00 | 74,700 | 0 | 74,700 | |
Mar 03 2014 | LEXG | LEXICON PHARMACEUT ... | Tessmer James F | VP, Finance & Accou ... | Option Exercise | M | 0.00 | 6,000 | 0 | 18,000 | |
Mar 03 2014 | LEXG | LEXICON PHARMACEUT ... | Tessmer James F | VP, Finance & Accou ... | Option Exercise | M | 0.00 | 6,750 | 0 | 13,500 | |
Mar 03 2014 | LEXG | LEXICON PHARMACEUT ... | Tessmer James F | VP, Finance & Accou ... | Option Exercise | M | 0.00 | 7,500 | 0 | 7,500 | |
Mar 03 2014 | LEXG | LEXICON PHARMACEUT ... | Tessmer James F | VP, Finance & Accou ... | Payment of Exercise | F | 1.92 | 6,612 | 12,695 | 61,641 | 68.3 K to 61.6 K (-9.69 %) |
Mar 03 2014 | LEXG | LEXICON PHARMACEUT ... | Tessmer James F | VP, Finance & Accou ... | Buy | M | 0.00 | 6,000 | 0 | 68,253 | 62.3 K to 68.3 K (+9.64 %) |
Mar 03 2014 | LEXG | LEXICON PHARMACEUT ... | Tessmer James F | VP, Finance & Accou ... | Buy | M | 0.00 | 6,750 | 0 | 62,253 | 55.5 K to 62.3 K (+12.16 %) |
Mar 03 2014 | LEXG | LEXICON PHARMACEUT ... | Tessmer James F | VP, Finance & Accou ... | Buy | M | 0.00 | 7,500 | 0 | 55,503 | 48 K to 55.5 K (+15.62 %) |
Feb 10 2014 | LEXG | LEXICON PHARMACEUT ... | Tessmer James F | VP, Finance & Accou ... | Option Exercise | A | 1.72 | 87,500 | 150,500 | 87,500 | |
Feb 10 2014 | LEXG | LEXICON PHARMACEUT ... | Tessmer James F | VP, Finance & Accou ... | Option Exercise | A | 0.00 | 37,500 | 0 | 37,500 | |
Mar 01 2013 | LEXG | LEXICON PHARMACEUT ... | Tessmer James F | VP, Finance & Accou ... | Option Exercise | M | 0.00 | 6,750 | 0 | 20,250 | |
Mar 01 2013 | LEXG | LEXICON PHARMACEUT ... | Tessmer James F | VP, Finance & Accou ... | Option Exercise | M | 0.00 | 7,500 | 0 | 15,000 | |
Mar 01 2013 | LEXG | LEXICON PHARMACEUT ... | Tessmer James F | VP, Finance & Accou ... | Payment of Exercise | F | 1.98 | 3,807 | 7,538 | 48,003 | 51.8 K to 48 K (-7.35 %) |
Mar 01 2013 | LEXG | LEXICON PHARMACEUT ... | Tessmer James F | VP, Finance & Accou ... | Buy | M | 0.00 | 6,750 | 0 | 51,810 | 45.1 K to 51.8 K (+14.98 %) |
Mar 01 2013 | LEXG | LEXICON PHARMACEUT ... | Tessmer James F | VP, Finance & Accou ... | Buy | M | 0.00 | 7,500 | 0 | 45,060 | 37.6 K to 45.1 K (+19.97 %) |
Feb 12 2013 | LEXG | LEXICON PHARMACEUT ... | Tessmer James F | VP, Finance & Accou ... | Option Exercise | A | 2.09 | 56,000 | 117,040 | 56,000 | |
Feb 12 2013 | LEXG | LEXICON PHARMACEUT ... | Tessmer James F | VP, Finance & Accou ... | Option Exercise | A | 0.00 | 24,000 | 0 | 24,000 | |
Feb 04 2013 | LEXG | LEXICON PHARMACEUT ... | Tessmer James F | VP, Finance & Accou ... | Option Exercise | M | 0.00 | 13,200 | 0 | 0 | |
Feb 04 2013 | LEXG | LEXICON PHARMACEUT ... | Tessmer James F | VP, Finance & Accou ... | Payment of Exercise | F | 2.11 | 4,310 | 9,094 | 37,560 | 41.9 K to 37.6 K (-10.29 %) |
Feb 04 2013 | LEXG | LEXICON PHARMACEUT ... | Tessmer James F | VP, Finance & Accou ... | Buy | M | 0.00 | 13,200 | 0 | 41,870 | 28.7 K to 41.9 K (+46.04 %) |
Mar 01 2012 | LEXG | LEXICON PHARMACEUT ... | Tessmer James F | VP, Finance & Accou ... | Option Exercise | M | 0.00 | 7,500 | 0 | 22,500 | |
Mar 01 2012 | LEXG | LEXICON PHARMACEUT ... | Tessmer James F | VP, Finance & Accou ... | Payment of Exercise | F | 1.78 | 2,299 | 4,092 | 28,670 | 31 K to 28.7 K (-7.42 %) |
Mar 01 2012 | LEXG | LEXICON PHARMACEUT ... | Tessmer James F | VP, Finance & Accou ... | Buy | M | 0.00 | 7,500 | 0 | 30,969 | 23.5 K to 31 K (+31.96 %) |
Feb 17 2012 | LEXG | LEXICON PHARMACEUT ... | Tessmer James F | VP, Finance & Accou ... | Option Exercise | A | 1.80 | 61,000 | 109,800 | 61,000 | |
Feb 17 2012 | LEXG | LEXICON PHARMACEUT ... | Tessmer James F | VP, Finance & Accou ... | Option Exercise | A | 0.00 | 27,000 | 0 | 27,000 | |
Feb 25 2011 | LEXG | LEXICON PHARMACEUT ... | Tessmer James F | VP, Finance & Accou ... | Option Exercise | A | 0.00 | 30,000 | 0 | 30,000 | |
Feb 25 2011 | LEXG | LEXICON PHARMACEUT ... | Tessmer James F | VP, Finance & Accou ... | Option Exercise | A | 1.81 | 70,000 | 126,700 | 70,000 | |
Feb 25 2011 | LEXG | LEXICON PHARMACEUT ... | Tessmer James F | VP, Finance & Accou ... | Payment of Exercise | F | 1.81 | 2,116 | 3,830 | 23,469 | 25.6 K to 23.5 K (-8.27 %) |
Feb 25 2011 | LEXG | LEXICON PHARMACEUT ... | Tessmer James F | VP, Finance & Accou ... | Grant | A | 0.00 | 6,906 | 0 | 25,585 | 18.7 K to 25.6 K (+36.97 %) |
Feb 17 2010 | LEXG | LEXICON PHARMACEUT ... | Tessmer James F | VP, Finance & Accou ... | Option Exercise | A | 0.00 | 13,200 | 0 | 13,200 | |
Feb 17 2010 | LEXG | LEXICON PHARMACEUT ... | Tessmer James F | VP, Finance & Accou ... | Option Exercise | A | 1.90 | 100,000 | 190,000 | 100,000 | |
Feb 17 2010 | LEXG | LEXICON PHARMACEUT ... | Tessmer James F | VP, Finance & Accou ... | Payment of Exercise | F | 1.91 | 3,934 | 7,514 | 18,679 | 22.6 K to 18.7 K (-17.40 %) |
Page: 1